Protective drugs in cancer therapy: optimal clinical testing and future directions.
D004999:Amifostine / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007525:Isoelectric Focusing; D009369:Neoplasms / Q000378:metabolism / Q000532:radiotherapy*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D013329:Structure-Activity Relationship
D011837:Radiation-Protective Agents; D004999:Amifostine